The Evolution of Oligometastatic Pancreatic Ductal Adenocarcinoma: From Anatomic Description to Biologically Informed Patient Selection
Metastatic pancreatic ductal adenocarcinoma (PDAC) has historically been managed with systemic therapy, and local therapies have, in general, been avoided in the absence of symptoms directly related to a specific metastasis. Even if a specific site of disease, such as a local recurrence, had the potential to cause symp...